SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Protara Therapeutics Files 424B5

Protara Therapeutics submits regulatory filing with the SEC. The filing provides updated information about the company.

TARA

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.